eucorvac-19
Vaccineexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
3
Phase 3
2
Phase 4
0
Earliest trial started Feb 23, 2021 (NCT04783311)
Timeline
Indications
Studied for
Mechanism of action
- SARS-CoV-2Immunity, active
SARS-CoV-2 immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05572879 | Phase 3 | Oct 1, 2022 | EuBiologics Co.,Ltd |
| NCT05603052 | Phase 3 | Jul 11, 2022 | EuBiologics Co.,Ltd |
| NCT04783311 | Phase 1/Phase 2 (Phase 2) | Feb 23, 2021 | EuBiologics Co.,Ltd |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| EuBiologics Co.,Ltd | For profit | 3 | 3 | 2 | 2021 |
1 organizations
Page 1 / 1